NCT01765192View on ClinicalTrials.gov

Roflumilast Plus Montelukast in Adults With Severe Asthma

PHASE2CompletedINTERVENTIONAL
Enrollment

64

Participants

Timeline

Start Date

February 28, 2013

Primary Completion Date

October 31, 2013

Study Completion Date

October 31, 2013

Conditions
Asthma
Interventions
DRUG

Roflumilast

Roflumilast was supplied in tablets.

DRUG

Roflumilast placebo

Roflumilast placebo was supplied in tablets.

DRUG

Montelukast

Montelukast was supplied in tablets.

Trial Locations (13)

Unknown

Berlin

Großhansdorf

Hamburg

Hanover

Mainz

Schwerin

Budapest

Nyíregyháza

Szarvas

Törökbálint

Bloemfontein

Cape Town

Pretoria

Sponsors

Lead Sponsor

AstraZeneca
All Listed Sponsors
lead

AstraZeneca

INDUSTRY